156 related articles for article (PubMed ID: 30018166)
1. Qualitative Evaluation of a Complex Intervention to Improve Rheumatic Heart Disease Secondary Prophylaxis.
Read C; Mitchell AG; de Dassel JL; Scrine C; Hendrickx D; Bailie RS; Johnston V; Maguire GP; Schultz R; Carapetis JR; Ralph AP
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018166
[TBL] [Abstract][Full Text] [Related]
2. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
[TBL] [Abstract][Full Text] [Related]
3. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
[TBL] [Abstract][Full Text] [Related]
4. Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial.
Ralph AP; Read C; Johnston V; de Dassel JL; Bycroft K; Mitchell A; Bailie RS; Maguire GP; Edwards K; Currie BJ; Kirby A; Carapetis JR
Trials; 2016 Jan; 17():51. PubMed ID: 26818484
[TBL] [Abstract][Full Text] [Related]
5. How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.
de Dassel JL; de Klerk N; Carapetis JR; Ralph AP
J Am Heart Assoc; 2018 Dec; 7(24):e010223. PubMed ID: 30561268
[TBL] [Abstract][Full Text] [Related]
6. Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.
Katzenellenbogen JM; Bond-Smith D; Ralph AP; Wilmot M; Marsh J; Bailie R; Matthews V
Aust Health Rev; 2020 Apr; 44(2):212-221. PubMed ID: 32241338
[TBL] [Abstract][Full Text] [Related]
7. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
[TBL] [Abstract][Full Text] [Related]
8. Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.
Jaiteh LES; Drammeh L; Anderson ST; Mendy J; Ceesay S; D'Alessandro U; Carapetis J; Mirabel M; Erhart A
BMC Cardiovasc Disord; 2021 Oct; 21(1):503. PubMed ID: 34663206
[TBL] [Abstract][Full Text] [Related]
9. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
[TBL] [Abstract][Full Text] [Related]
10. Community-based participatory action research on rheumatic heart disease in an Australian Aboriginal homeland: Evaluation of the 'On track watch' project.
Haynes E; Marawili M; Marika BM; Mitchell AG; Phillips J; Bessarab D; Walker R; Cook J; Ralph AP
Eval Program Plann; 2019 Jun; 74():38-53. PubMed ID: 30849711
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
Rémond MG; Coyle ME; Mills JE; Maguire GP
Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
[TBL] [Abstract][Full Text] [Related]
12. Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.
Haran S; Crane N; Kazi S; Axford-Haines L; White A
Aust J Rural Health; 2018 Apr; 26(2):119-125. PubMed ID: 29168587
[TBL] [Abstract][Full Text] [Related]
13. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory.
Carapetis JR; Wolff DR; Currie BJ
Med J Aust; 1996 Feb; 164(3):146-9. PubMed ID: 8628132
[TBL] [Abstract][Full Text] [Related]
14. A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia.
Kerrigan V; Kelly A; Lee AM; Mungatopi V; Mitchell AG; Wyber R; Ralph AP
BMC Health Serv Res; 2021 Oct; 21(1):1127. PubMed ID: 34670567
[TBL] [Abstract][Full Text] [Related]
15. Ending rheumatic heart disease in Australia: the evidence for a new approach.
Wyber R; Noonan K; Halkon C; Enkel S; Cannon J; Haynes E; Mitchell AG; Bessarab DC; Katzenellenbogen JM; Bond-Smith D; Seth R; D'Antoine H; Ralph AP; Bowen AC; Brown A; Carapetis JR;
Med J Aust; 2020 Nov; 213 Suppl 10():S3-S31. PubMed ID: 33190287
[TBL] [Abstract][Full Text] [Related]
16. Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery.
Wilson N
World J Pediatr Congenit Heart Surg; 2013 Oct; 4(4):380-4. PubMed ID: 24327631
[TBL] [Abstract][Full Text] [Related]
17. Poor long-term adherence to secondary penicillin prophylaxis in children with history of rheumatic fever.
Amarilyo G; Chodick G; Zalcman J; Koren G; Levinsky Y; Somekh I; Harel L
Semin Arthritis Rheum; 2019 Jun; 48(6):1019-1024. PubMed ID: 30415945
[TBL] [Abstract][Full Text] [Related]
18. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
[TBL] [Abstract][Full Text] [Related]
19. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
[TBL] [Abstract][Full Text] [Related]
20. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.
Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE
Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
